Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Baohong Yuan, Danyan Liu, Zunyan Zhu, Yonggang Hao, Kaihua He & Shiyun Deng. (2022) Effect of Thoracic Paravertebral Nerve Block on Blood Coagulation in Patients After Thoracoscopic Lobectomy: A Prospective Randomized Controlled Clinical Trial. Journal of Pain Research 15, pages 633-641.
Read now
Read now
Marina Panova-Noeva & Anna Falanga. (2010) Treatment of thromboembolism in cancer patients. Expert Opinion on Pharmacotherapy 11:12, pages 2049-2058.
Read now
Read now
Gary H. Lyman, Alok A. Khorana, Nicole M. Kuderer & Agnes Y. Lee. (2009) Cancer and Thrombosis: Back to the Future Renewed Interest in an Old Problem. Cancer Investigation 27:5, pages 472-473.
Read now
Read now
Articles from other publishers (30)
Charles Hsu, Rushad Patell & Jeffrey I. Zwicker. (2023) The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis. Blood Advances 7:17, pages 4721-4727.
Crossref
Crossref
Wei-Juan Tan, Lu Chen, Sheng-Jie Yang, Bao-Ying Zhang, Ming-Li Sun, Yu-Bin Lin & Xing-He Wang. (2023) Development and Validation of a Prediction Model for Venous Thrombus Embolism (VTE) in Patients With Colorectal Cancer. Technology in Cancer Research & Treatment 22.
Crossref
Crossref
Gileh-Gol Akhtar-Danesh, Noori Akhtar-Danesh & Yaron Shargall. (2022) Venous Thromboembolism in Surgical Lung Cancer Patients: A Provincial Population-Based Study. The Annals of Thoracic Surgery 114:3, pages 890-897.
Crossref
Crossref
Gileh-Gol Akhtar-Danesh, Noori Akhtar-Danesh & Yaron Shargall. (2022) Venous Thromboembolism in Surgically Treated Esophageal Cancer Patients: A Provincial Population-Based Study. TH Open 06:03, pages e168-e176.
Crossref
Crossref
Lihui Ke, Songping Cui, Shuo Chen, Bin Hu & Hui Li. (2020) Dynamics of D‐dimer in non‐small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism. Thoracic Cancer 11:9, pages 2483-2492.
Crossref
Crossref
Evangelos Dimakakos, Elias Kotteas, Georgia Gomatou, Theodora Katsarou, Vassilis Vlahakos, Ioannis Vathiotis, Sofia Talagani, Ioannis Dimitroulis & Konstantinos Syrigos. (2020) Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review. Vascular Medicine 25:3, pages 255-262.
Crossref
Crossref
Miao Liu, Guiyue Wang, Yuhang Li, Hongliang Wang, Haitao Liu, Nana Guo, Ci Han, Yahui Peng, Mengyuan Yang, Yansong Liu, Xiaohui Ma, Kaijiang Yu & Changsong Wang. (2020) Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology 12, pages 175883592090754.
Crossref
Crossref
Zilun Li, Guolong Zhang, Mengping Zhang, Jie Mei, Huiwen Weng & Zhenwei Peng. (2020) Development and Validation of a Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer. Clinical and Applied Thrombosis/Hemostasis 26, pages 107602962091079.
Crossref
Crossref
Sahrun Sahrun & Laksmi Wulandari. (2019) Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy. Folia Medica Indonesiana 55:3, pages 239.
Crossref
Crossref
Carolina Vitale, Maria D’Amato, Paolo Calabrò, Anna Agnese Stanziola, Mauro Mormile & Antonio Molino. (2015) Venous thromboembolism and lung cancer: a review. Multidisciplinary Respiratory Medicine 10:1.
Crossref
Crossref
H. Schinzel. (2018) Heparins – DOACS – VKA. Phlebologie 44:06, pages 307-315.
Crossref
Crossref
Aaron J. Krych, Paul L. Sousa, Joseph A. Morgan, Bruce A. Levy, Michael J. Stuart & Diane L. Dahm. (2015) Incidence and Risk Factor Analysis of Symptomatic Venous Thromboembolism After Knee Arthroscopy. Arthroscopy: The Journal of Arthroscopic & Related Surgery 31:11, pages 2112-2118.
Crossref
Crossref
P. C. van der Sluis, I. Ubink, S. van der Horst, J. J. Boonstra, E. E. Voest, J. P. Ruurda, I. H. M. Borel Rinkes, M. J. Wiezer, M. E. I. Schipper, P. D. Siersema, M. Los, M. P. Lolkema & R. van Hillegersberg. (2015) Safety, Efficacy, and Long-Term Follow-Up Evaluation of Perioperative Epirubicin, Cisplatin, and Capecitabine Chemotherapy in Esophageal Resection for Adenocarcinoma. Annals of Surgical Oncology 22:5, pages 1555-1563.
Crossref
Crossref
Ilana Kopolovic, Agnes Y. Y. Lee & Cynthia Wu. (2014) Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study. Annals of Hematology 94:2, pages 329-336.
Crossref
Crossref
Yoshiki Yamashita, Hideo Wada, Hideki Nomura, Toshiro Mizuno, Kanako Saito, Norikazu Yamada, Kunihiro Asanuma, Masanobu Usui, Yuki Kamimoto, Takeshi Matsumoto, Kohshi Ohishi & Naoyuki Katayama. (2014) Elevated Fibrin-related Markers in Patients with Malignant Diseases Frequently Associated with Disseminated Intravascular Coagulation and Venous Thromboembolism. Internal Medicine 53:5, pages 413-419.
Crossref
Crossref
Bohdan Kadlec, Jana Skrickova, Zdenek Merta, Ladislav Dusek & Jiri Jarkovsky. (2014) The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer. The Scientific World Journal 2014, pages 1-9.
Crossref
Crossref
Agnes YY Lee, Rupert Bauersachs, Mette S Janas, Mikala F Jarner, Pieter W Kamphuisen, Guy Meyer & Alok A Khorana. (2013) CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer 13:1.
Crossref
Crossref
M. Mandala`, M. Clerici, I. Corradino, C. Vitalini, S. Colombini, V. Torri, A. De Pascale & S. Marsoni. (2012) Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the ‘SENDO experience’. Annals of Oncology 23:6, pages 1416-1421.
Crossref
Crossref
Alexandra Brown. (2012) Preventing venous thromboembolism in hospitalized patients with cancer: Improving compliance with clinical practice guidelines. American Journal of Health-System Pharmacy 69:6, pages 469-481.
Crossref
Crossref
A. Falanga & L. Russo. (2011) Epidemiology, risk and outcomes of venous thromboembolism in cancer. Hämostaseologie 32:2, pages 115-125.
Crossref
Crossref
Maria Teresa Sartori, Alessandro Della Puppa, Andrea Ballin, Graziella Saggiorato, Daniela Bernardi, Andrea Padoan, Renato Scienza, Domenico d’Avella & Giuseppe Cella. (2010) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. Journal of Neuro-Oncology 104:1, pages 225-231.
Crossref
Crossref
Ms Meinir Elen Hughes. (2011) PICC-Related Thrombosis: Pathophysiology, Incidence, Morbidity and the Effect of Ultrasound-Guided Placement Technique on Occurrence in Cancer Patients. Journal of the Association for Vascular Access 16:1, pages 8-18.
Crossref
Crossref
Nuno Cardim, Júlia Toste, Vanessa Carvalho, Igor Nunes, Daniel Ferreira, Vanda Carmelo, Ana SN Oliveira, José Ferro, Sylvie Mariana, Adelaide Almeida, Francisco P Machado & José Roquette. (2010) Playing games with a thrombus: a dangerous match. Paradoxical embolism from a huge central venous cathether thrombus: a case report. Cardiovascular Ultrasound 8:1.
Crossref
Crossref
Joanne L. Yu, Rosie Xing, Chloe Milsom & Janusz Rak. (2010) Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1. Thrombosis Research 126:1, pages e6-e10.
Crossref
Crossref
Hideki Nomura, Hideo Wada, Toshiro Mizuno, Yoshiki Yamashita, Kanako Saito, Shigehisa Kitano, Naoyuki Katayama, Norikazu Yamada, Takashi Sugiyama, Akihiro Sudo, Masanobu Usui, Shuji Isaji & Tsutomu Nobori. (2009) Elevated Fibrin-Related Markers in Patients with Malignant Diseases Suspected of Having Thrombotic Disorders. Clinical and Applied Thrombosis/Hemostasis 16:3, pages 266-272.
Crossref
Crossref
Mauro Campanini, Gualberto Gussoni, Mauro Silingardi, Gianluigi Scannapieco, Carlo Buniolo, Antonella Valerio, Walter Ageno, Ido Iori & Antonino Mazzone. (2010) Fattori di rischio per tromboembolismo venoso e profilassi nei pazienti ricoverati in Medicina Interna: analisi dallo studio FADOI “GEMINI”. Italian Journal of Medicine 4:1, pages 23-31.
Crossref
Crossref
Gary H. Lyman. (2009) Thromboprophylaxis with low‐molecular‐weight heparin in medical patients with cancer. Cancer 115:24, pages 5637-5650.
Crossref
Crossref
Alok A. KhoranaMichael B. StreiffDominique FargeMario MandalaPhilippe DebourdeauFrancis CajfingerMichel MartyAnna FalangaGary H. Lyman. (2009) Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action. Journal of Clinical Oncology 27:29, pages 4919-4926.
Crossref
Crossref
Gary H. Lyman & Alok A. Khorana. (2009) Cancer, Clots and Consensus: New Understanding of an Old Problem. Journal of Clinical Oncology 27:29, pages 4821-4826.
Crossref
Crossref
Giancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, Melina Verso, Mario Mandalà, Luigi Cavanna, Sandro Barni, Roberto Labianca, Franco Buzzi, Giovanni Scambia, Rodolfo Passalacqua, Sergio Ricci, Giampietro Gasparini, Vito Lorusso, Erminio Bonizzoni & Maurizio Tonato. (2009) Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. The Lancet Oncology 10:10, pages 943-949.
Crossref
Crossref